GSK
For UK Healthcare Professionals
Articles on other parts of this website may contain promotional information

Identifying the right patients for remote COPD reviews


  • Reading time

    5 min read

  • Rating

    11
    0
  • Your expert

    Expert Placeholder
    GSK

Proactively identifying the right patients is an important part of initiating remote COPD reviews. When reviewing patients reactively (e.g. when then are unwell with their COPD or come with some other concern) there is a risk that those with greatest need for changes to their care may be many months away from their review. Proactive identification of greatest need outside of the regular review cycle is therefore important.

How can you identify patients for remote COPD reviews?

Whether doing an in-person or remote review, patients may come to you through several ways including triage, routine review or prioritised review. It's important to have good processes in place to ensure you identify the right patient group for review. Watch the video by Daniel Hughes and Scott Sutton of Interface Clinical Services to understand how this may happen for COPD patients.


Video from the Best Practice in Remote Consultations webinar

How can you prioritise patients for remote respiratory COPD reviews?

Once you've defined the group you'd like to review, the next step is identifying the patients themselves. Identifying individual patients can sometimes be a challenge however there are a few ways you can do this. Watch the video by Daniel Hughes and Scott Sutton of Interface Clinical Services as they explain how you can identify the patients for remote COPD reviews. 


Video from the Best Practice in Remote Consultations webinar

Summary 

Anecdotal evidence indicates some practices mobilised shielding staff members to conduct remote COPD reviews, and for the first time are ahead of plan with their annual COPD reviews. Whilst proactively identifying patients can sometimes seem tricky, committing the time and resource to doing it properly could prove beneficial in improving your patient’s care, especially those most at risk. Taking a proactive approach for those most in need of a review may also support in the reduction of admissions and healthcare utilisation in the longer term too. For further information, you may also want to read the BMA RCGP guidance referenced in this video.

 

Once you have your list of patients for remote COPD reviews you may want to find more about the review itself. To get some tips on how to conduct an effective remote COPD review, check out our article 'What does a remote COPD review involve'.

NP-GB-RS-WCNT-200018 July 2020

Rate this article

  • Reading time

    5 min read

  • Rating

    11
    0
  • Your expert

    Expert Placeholder
    GSK